The generated products miR-1207-5p and miR-1207-3p inhibit sarcoma gene (SRC) and ras homolog family member A (RhoA), respectively, to increase the sensitivity of pancreatic cancer cells to gemcitabine chemotherapy (29). The gene discussed is RHOA; the disease is pancreatic neoplasm.